文献速递头颈外科

同时性食管癌与头颈癌患者全身炎症反应标志物的预后意义

Prognostic significances of systemic inflammatory response markers in patients with synchronous esophageal and head and neck cancers.
PubMed 文献 · Head Neck · 2024-02-12

本研究连续纳入717例新诊断头颈鳞状细胞癌(HNSCC)并接受治疗前食管内镜筛查的患者,分析治疗前中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)和淋巴细胞与单核细胞比值(LMR)与临床因素的关系。103例(14.4%)发现同时性食管鳞状细胞癌(ESCC),与较低绝对淋巴细胞计数(p<0.001)、较高NLR(p=0.044)和较低LMR(p=0.001)相关,而与PLR无关(p=0.49)。LMR<4(OR 2.22;95%CI 1.27-3.88,p=0.005)、饮酒(OR 4.19;95%CI 1.47-11.91,p=0.007)、肿瘤位于咽部(OR 1.68;95%CI 1.07-2.64,p=0.025)和低体重指数(OR 0.94;95%CI 0.88-0.99,p=0.039)是发生同时性ESCC的危险因素。低LMR与总生存期下降显著相关(p<0.0001),在同时性和非同时性组中均如此。多因素分析显示,LMR<4(HR 1.97;95%CI 1.38-2.81,p<0.001)、低BMI(HR 0.96;95%CI 0.93-0.99,p=0.044)和存在同时性ESCC(HR 1.56;95%CI 1.10-2.22,p=0.013)是HNSCC患者的独立预后因素。结论:将LMR与其他已识别的危险因素(如饮酒、肿瘤位于咽部和低BMI)结合,可能建立更高效的HNSCC患者食管探查筛查方案。LMR的意义还提示抗癌免疫可能在多原发癌发生的癌化过程中发挥作用,免疫治疗未来可能有预防或作为同时性鳞状细胞癌辅助治疗的潜力。

要点

  • HNSCC患者中14.4%(103/717)发现同时性ESCC。
  • LMR<4、饮酒、肿瘤位于咽部和低BMI是同时性ESCC的危险因素。
  • LMR<4、低BMI和同时性ESCC是HNSCC患者的独立预后因素。

核心结论

  • 将LMR与其他已识别的危险因素(饮酒、肿瘤位于咽部、低BMI)结合,可能建立更高效的HNSCC患者食管探查筛查方案。
  • LMR的意义提示抗癌免疫可能在多原发癌发生的癌化过程中发挥作用,免疫治疗未来可能有预防或作为同时性鳞状细胞癌辅助治疗的潜力。

研究设计与样本

  • 连续纳入717例新诊断HNSCC并接受治疗前食管内镜筛查的患者。
  • 计算并分析治疗前NLR、LMR和PLR,并与临床因素比较。

主要发现

  • 103例(14.4%)发现同时性ESCC,与较低绝对淋巴细胞计数(p<0.001)、较高NLR(p=0.044)和较低LMR(p=0.001)相关,而与PLR无关(p=0.49)。
  • ROC曲线验证存在同时性ESCC的最佳截断值:NLR为2.5,LMR为4.0。
  • 多因素logistic回归显示LMR<4(OR 2.22;95%CI 1.27-3.88,p=0.005)、饮酒(OR 4.19;95%CI 1.47-11.91,p=0.007)、肿瘤位于咽部(OR 1.68;95%CI 1.07-2.64,p=0.025)和低BMI(OR 0.94;95%CI 0.88-0.99,p=0.039)是发生同时性ESCC的危险因素。
  • 低LMR与总生存期下降显著相关(p<0.0001),在同时性和非同时性组中均如此。
  • 多因素分析显示LMR<4(HR 1.97;95%CI 1.38-2.81,p<0.001)、低BMI(HR 0.96;95%CI 0.93-0.99,p=0.044)和存在同时性ESCC(HR 1.56;95%CI 1.10-2.22,p=0.013)是HNSCC患者的独立预后因素。

关键数值与推荐

  • LMR<4的OR为2.22(95%CI 1.27-3.88,p=0.005),作为同时性ESCC的危险因素。
  • 饮酒的OR为4.19(95%CI 1.47-11.91,p=0.007),作为同时性ESCC的危险因素。
  • 肿瘤位于咽部的OR为1.68(95%CI 1.07-2.64,p=0.025),作为同时性ESCC的危险因素。
  • 低BMI的OR为0.94(95%CI 0.88-0.99,p=0.039),作为同时性ESCC的危险因素。
  • LMR<4的HR为1.97(95%CI 1.38-2.81,p<0.001),低BMI的HR为0.96(95%CI 0.93-0.99,p=0.044),同时性ESCC的HR为1.56(95%CI 1.10-2.22,p=0.013),均为HNSCC患者的独立预后因素。

临床怎么用

  • 将LMR与其他已识别的危险因素(饮酒、肿瘤位于咽部、低BMI)结合,可能建立更高效的HNSCC患者食管探查筛查方案。
  • LMR的意义提示抗癌免疫可能在多原发癌发生的癌化过程中发挥作用,免疫治疗未来可能有预防或作为同时性鳞状细胞癌辅助治疗的潜力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with head and neck squamous cell carcinoma (HNSCC) frequently develop synchronous esophageal cancer (ESCC), but there is a lack of clinical predictors. The neutrophil to lymphocyte (NLR), platelet to lymphocyte (PLR), and lymphocyte to monocyte ratios (LMRs), reflect the balance between pro-cancer inflammation and anti-cancer immune responses, but their role in HNSCC and synchronous cancer remain uncertain. METHOD: The study consecutively enrolled a total of 717 patients with newly diagnosed HNSCC who received pre-treatment esophageal endoscopic screening. The pretreatment NLR, LMR and PLRs were calculated and analyzed in comparison with the clinical factors. RESULTS: A total of 103 patients (14.4%) were found to have synchronous ESCCs, and were associated with a significantly lower absolute lymphocyte count (p < 0.001), higher NLRs (p = 0.044) and lower LMRs (p = 0.001), but not PLRs (p = 0.49). The ROC curve for the presence of synchronous ESCC verified the optimal cutoff value as 2.5 for NLRs and 4.0 for LMRs. Multivariable logistic regression revealed that a LMR <4 (OR 2.22; 95% CI 1.27-3.88, p = 0.005), alcohol consumption (OR 4.19; 95% CI 1.47-11.91, p = 0.007), tumor location over the pharynx (OR 1.68; 95% CI 1.07-2.64, p = 0.025), and low body mass index (OR 0.94; 95% CI 0.88-0.99, p = 0.039) were risk factors for developing synchronous ESCC. A low-LMR was significantly associated with decreases in overall survival (p < 0.0001), in both synchronous and non-synchronous groups. Multivariate analysis demonstrated that LMR <4 (HR 1.97; 95% CI 1.38-2.81, p < 0.001), a low-BMI (HR 0.96; 95% CI 0.93-0.99, p = 0.044) and presence of synchronous ESCC (HR 1.56; 95% CI 1.10-2.22, p = 0.013) were independent prognostic factors for HNSCC patients. CONCLUSION: Incorporation of LMR into other identified risk factors, such as alcohol consumption, tumor location over pharynx, and low-BMI, may establish a more efficient screening program for esophageal exploration in HNSCC patients. The significances of LMR also suggest that anti-cancer immunity may play a role in the filed cancerization to initiate multiple cancers, and the immunotherapy may have potentials for prevention or as an adjuvant treatment for synchronous SCC in the future.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Wang CC, Hsu MH, Lee CT, et al. Prognostic significances of systemic inflammatory response markers in patients with synchronous esophageal and head and neck cancers. Head Neck. 2024. PMID: 38344911. doi:10.1002/hed.27677

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。